Literature DB >> 3340251

Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.

Y Kobayashi1, K Fujii, Y Hiki, S Tateno, A Kurokawa, M Kamiyama.   

Abstract

29 patients with IgA nephropathy whose proteinuria persisted at a level of 2.0 g/day or more and who received prednisolone treatment for 1-3 years were retrospectively evaluated on their clinical courses. 13 of 14 patients with renal dysfunction of less than 70 ml/min in initial creatinine clearance (Ccr) values subsequently entered a progressive course during a follow-up period of 47 months, leading to end-stage renal failure in 8 cases. On the other hand, only 1 of the other 15 patients with preserved renal function of 70 ml/min or more ended up with end-stage renal failure during a follow-up period of 74 months, although 7 underwent a progressive course. Three patients in the latter group experienced a prominent reduction in proteinuria to less than 1.0 g/day and maintained renal function. Meanwhile, the steroid group of moderate proteinuric patients with a creatinine clearance greater than 70 ml/min had a benign course, while the nonsteroid group had an unfavorable one. These results suggest that steroid therapy in IgA nephropathy may be able to stabilize a progressive course, especially in the early stage of the disease, although, because they come from an uncontrolled study, a definite conclusion cannot be drawn.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340251     DOI: 10.1159/000184861

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors.

Authors: 
Journal:  BMJ       Date:  1991-02-09

2.  Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells.

Authors:  Hideki Kimura; Xuan Li; Kunio Torii; Toshiharu Okada; Kazuko Kamiyama; Daisuke Mikami; Kenji Kasuno; Naoki Takahashi; Haruyoshi Yoshida
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

Review 3.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

4.  Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.

Authors:  Ozlem Harmankaya; Yahya Oztürk; Taner Baştürk; Aydoğan Obek; Işin Kiliçarslan
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

5.  The improvement of renal survival with steroid pulse therapy in IgA nephropathy.

Authors:  Ritsuko Katafuchi; Toshiharu Ninomiya; Tohru Mizumasa; Kiyoshi Ikeda; Harumitsu Kumagai; Masaharu Nagata; Hideki Hirakata
Journal:  Nephrol Dial Transplant       Date:  2008-07-20       Impact factor: 5.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.